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CHAPTER(1(INTRODUCTION(
1.1(Diabetes(Mellitus(
!

Metabolism!is!a!sequence!of!biochemical!reactions!that!take!place!in!every!

single! cell! and! organ! to! maintain! the! organism! growth,! reproduction,! damage!
repair,!and!adaptation!to!the!surrounding!environment![1].!These!reactions!involve!
catabolism!and!anabolism!using!the!major!sources!of!energy:!proteins,!lipids,!and!
carbohydrates.! Furthermore,! any! disruption! in! the! regulation! of! the! metabolic!
processes!affects!the!individual’s!morbidity!and!mortality![1].!Accordingly,!in!this!
chapter,! we! are! going! to! discuss! diabetes! mellitus,! which! is! one! of! the! main!
metabolic!disorders.!
1.1.1(Pancreatic(Regulation(of(Blood(Glucose(
The!regulation!of!the!cornerstone!of!the!entire!body’s!energy,!glucose,!in!
the! blood! stream! by! the! pancreas,! specifically! the! islets! of! Langerhans,! is! very!
critical! through! the! secretion! of! insulin! and! glucagon.! Insulin,! which! is! secreted!
from!beta!cells!of!the!islets!of!Langerhans!in!response!to!high!blood!glucose!levels,!
has! an! anabolic! effect! via! its! stimulation! of! glucose! uptake! in! insulin! sensitive!
tissues,! such! as! skeletal! muscle! and! adipose! tissue! to! be! stored! in! the! form! of!
glycogen!and!fat![2].!On!the!other!hand,!low!glucose!levels!enhance!the!secretion!
of!glucagon!from!pancreatic!alpha!cells,!and!this!plays!the!catabolic!role!through!
stimulation! of! stored! glycogen! breakdown! and! formation! of! glucose! from! nonS
carbohydrate! sources! via! glycogenolysis! and! hepatic! gluconeogenesis,!
respectively![2].!This!mechanism!is!well!controlled!through!the!opposite!secretion!

!
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of!these!hormones!in!response!to!the!blood!glucose!level!and!their!physiological!
efficacy! in! the! central! as! well! as! peripheral! tissues.! Any! disruption! in! this!
mechanism! leads! to! abnormal! glucose! levels,! either! hyperglycemia! or!
hypoglycemia,! that! result! in! serious! complications! [3].! For! instance,! prolonged!
uncontrolled! hyperglycemia! results! in! microvascular! and! macrovascular!
complications.!

The!

common!

microvascular!

complications!

of!

chronic!

hyperglycemia! are! nephropathy,! neuropathy,! and! retinopathy.! And,! the!
macrovascular!complications!that!may!result!from!uncontrolled!high!blood!glucose!
levels! are! coronary! artery! disease,! peripheral! arterial! disease,! and! stroke! [4].!
These!complications!are!the!main!source!of!increased!morbidity!and!mortality!in!
people!who!suffer!from!disrupted!glucose!regulation,!i.e.,!diabetes.!
1.1.2(Diabetes(Background(and(Epidemiology(
The!most!wellSknown!form!of!glucose!regulation!disturbance!is!the!epidemic!
disease!“diabetes!mellitus”.!This!disease!is!generally!characterized!by!abnormal!
insulin!levels!or!activities!in!response!to!blood!glucose!that!consequently!affect!the!
glucose! uptake! into! tissues! [5].! There! are! two! major! types! of! diabetes! mellitus,!
Type!I,!which!is!manifested!by!insufficient!insulin!secretion!from!beta!cells,!and!
Type!II,!which!is!characterized!by!relative!insulin!deficiency!and!decreased!insulin!
sensitivity!in!the!target!tissues!(i.e.,!insulin!resistance)![5,!6].!Type!I!Diabetes!is!
also!known!as!Insulin!Dependent!Diabetes!since!it!could!be!simply!managed!by!
exogenous!insulin!administration.!In!contrast,!Type!II!Diabetes,!which!is!known!as!
NonSInsulinSDependent! Diabetes,! is! one! of! the! greatest! challenges! that! human!
beings!face!nowadays!due!to!its!serious!complications!that!threaten!human!lives.!

!
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Even!though!the!mechanism!by!which!Type!II!Diabetes!is!developed!is!still!unclear,!
studies!show!that!there!are!many!risk!factors,!such!as!genetic!factors,!unhealthy!
lifestyle,! and! some! diseases,! that! increase! the! likelihood! of! developing! insulin!
resistance!and!further!Type!II!diabetes!mellitus![7S9].!Statistically,!according!to!the!
Centers! for! Disease! Control! and! Prevention,! there! were! 29.1! million! diabetic!
people! in! the! United! States! in! 2012.! This! represents! about! 9.3%! of! the! United!
States! population.! Moreover,! 90S95%! of! these! diabetics! are! NonSInsulin!
Dependent! (Type! II)! patients.! In! addition,! the! hospital! admission! rate! of! heart!
attack!cases!in!people!aged!20!or!older!was!1.8!higher!in!diabetic!patients!than!
nonSdiabetics!in!2010.!In!the!same!year,!60%!of!amputation!cases!of!lower!limbs!
that!did!not!result!from!trauma!in!people!aged!20!or!older!people!were!from!patients!
diagnosed!with!diabetes.!Furthermore,!in!2005S2008,!4.2!million!diabetic!people!
aged!40!or!older!were!diagnosed!with!retinopathy.!In!2011,!44%!of!individuals!with!
newly!diagnosed!renal!failure!were!diabetics.!Moreover,!diabetes!was!the!primary!
cause!of!10S15%!death!cases!in!2010.!In!addition!to!all!of!the!previously!mentioned!
data! about! diabetes! and! its! complications,! 37%! of! United! States! adults! were!
prediabetics,!those!who!have!high!fasting!blood!glucose!or!HbA1c!levels!but!not!
high!enough!to!be!classified!as!T2D,!in!the!period!2009S2012.!These!individuals!
are! likely! to! become! Type! II! diabetics! in! 10! years! or! less! and! the! long! term!
complications!may!have!already!begun.!Economically,!the!total!estimated!cost!of!
diabetes!in!the!United!States!in!2012!was!$245!billion.!These!physiological!and!
statistical!data!make!diabetes,!especially!T2D,!one!of!the!most!serious!epidemic!

!
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diseases! that! require! further! investigations! to! identify! the! etiologies! and!
mechanisms!behind!their!pathogenesis.!
1.1.3(Insulin(Resistance(and(T2D(
!

Insulin! insensitivity! or! “insulin! resistance”! is! a! major! manifestation! that! is!

denoted! in! nearly! all! Type! II! diabetes! patients.! In! addition,! as! mentioned!
previously,! studies! have! proposed! several! predisposing! factors! behind! the!
development!of!insulin!resistance,!including:!(1)!genetic!defects!of!proteinSprotein!
interactions!in!insulin!signaling!pathways!(2)!some!diseases,!such!as!Polycystic!
Ovarian!Syndrome!(3)!unhealthy!lifestyle,!e.g.!improper!eating!habits!that!result!in!
obesity![7S10].!This!in!turn,!opens!up!new!questions!about!Type!II!Diabetes!Mellitus!
and! leads! to! increasing! the! focus! of! the! extensive! diabetes! research! on! insulin!
signaling!pathways!to!point!out!the!detailed!sequence!of!biochemical!cascades!of!
insulin!actions.!!
There!are!three!major!energy!storage!tissues,!skeletal!muscle,!liver,!and!
adipose!tissue,!where!insulin!anabolic!activity!mainly!occurs.!Skeletal!muscle,!in!
particular,! plays! a! major! role! in! glucose! homeostasis! through! its! insulinS! and!
exerciseSinduced!glucose!uptake!to!maintain!euglycemia![11].!!
During!the!last!few!decades,!insulin!sensitivity!in!the!main!glucose!utilizing!
tissues! has! been! a! flash! point! in! diabetes! research,! and! many! studies! have!
successfully!pointed!out!the!impact!of!impaired!insulin!signaling!in!these!tissues!
on!the!development!of!T2D![11]!

!

!

5!

1.2(PostUTranslational(Modifications(and(Type(2(Diabetes(
1.2.1(PostUTranslational(Modifications(
After! translation,! proteins! such! as! enzymes,! receptors,! and! cellSsignaling!
messengers!undergo!numerous!reversible!and!irreversible!cellular!modifications!
[12].! Single! or! different! reactions! of! a! specificSsignalStriggered! and/or! a! timeS
induced!modification!could!take!place!in!a!given!protein!and!mandate!the!protein!
structure! and! function,! control! its! locations,! and! affect! the! proteinSprotein!
interactions![12S15].!
Many!proteins!PTMs!have!been!reported!in!the!past!few!decades.!However,!
only! a! handful! of! them! have! been! studied! reasonably,! e.g.,! phosphorylation,!
acetylation,!and!ubiquitination.!
One! of! the! wellSknown! reversible! PTMs! that! is! involved! in! controlling!
proteinSprotein!interactions!in!signaling!pathways!and!regulating!enzymes!activity,!
activation! and! inactivation,! is! protein! phosphorylation! through! the! counterS
regulatory! actions! of! kinase! or! phosphorylase,! that! catalyze! the! transfer! of! a!
phosphate! group! from! ATP/GTP! to! a! specific! residue! on! a! protein,! and!
phosphatase,! which! catalyzes! the! removal! of! phosphate! groups! from!
phosphoproteins! [16].! In! response! to! a! particular! cellular! condition,!
kinases/phosphorylases! and! phosphatases! may! switch! a! protein! on! or! off.! For!
instance,!in!case!of!hyperglycemia,!insulin!binds!to!its!receptor!on!the!muscle!cells!
triggering!IRS!phosphorylation!that!results!in!activation!of!the!kinase!Akt,!which!
eventually! facilitates! the! translocation! of! GLUT4! to! the! plasma! membrane! to!
induce! glucose! uptake! [17].! Therefore,! it! is! necessary! to! identify! specific!

!
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phosphorylated/dephosphorylated! proteins! under! a! certain! cellular! condition! to!
understand!the!role!of!phosphorylation!in!cellular!homeostasis!in!response!to!that!
condition.!
Acetylation!is!another!common!PTM!that!is!involved!in!cellular!regulation.!
Studies! have! shown! that! the! reversible! acetylation! of! NSterminal! and! lysine!
residues!antagonizes!the!action!of!protein!phosphorylation.!The!best!example!to!
illustrate! the! phosphorylationSacetylation! switch! is! the! regulation! of! the!
transcription!factor!STAT1!signaling.!Deacetylation!of!STAT1!allows!the!cytokinesS
stimulated!STAT1!phosphorylation!to!take!place!and!further!switch!STAT1!to!the!
active!form.!Then,!histone!acetyltransferase!catalyzes!the!phosphorylated!STAT1!
acetylation!and!facilitates!the!binding!of!phosphatase!(TCP45)!to!phosphoSSTAT1!
[18].! Upon! the! complex! formation,! TCP45! inactivates! STAT1! through!
dephosphorylation![18].!!In!addition,!acetylation!plays!a!key!role!in!protein!stability,!
DNA! recognition,! and! proteinSprotein! interactions.! Particularly,! lysine! acetylation!
has!a!major!role!in!regulating!cellular!metabolic!activity![19].!Studies!have!shown!
that! all! the! enzymes! that! are! involved! in! glycolysis,! gluconeogenesis,! the! urea!
cycle,!the!TCA!cycle,!lipolysis,!and!glycogenolysis!are!acetylated!in!hepatocytes!
[20].!
!

Addition!and!removal!of!a!small!(8!kDa)!protein,!ubiquitin,!which!is!made!up!

of!76!amino!acids!to!proteins,!is!another!pattern!of!PTMs.!This!protein,!ubiquitin,!
is!highly!conserved!from!yeast!to!human!and!its!conjugation!to!a!substrate!can!be!
singly!(monoS)!or!in!a!chain!(polyubiquitination)![21].!It!was!discovered!in!the!early!
1980s!within!research!studying!ATPSdependent!proteolysis![22].!Three!classes!of!

!

!

7!

enzymes,!(E1)!ubiquitin!activating!enzymes,!(E2)!ubiquitin!conjugating!enzymes,!
and!(E3)!ubiquitin!ligating!enzymes,!which!catalyzes!the!addition!of!the!activated!
ubiquitin! to! the! targeted! substrate,! facilitate! the! binding! of! ubiquitin! to! the! NS
terminal!amino!acid!or!a!lysine!residue![21,!23]!(See!Fig!2).!On!the!other!hand,!the!
deubiquininase! class! of! enzymes! counteracts! the! ubiquitin! conjugation! and!
catalyzes! the! ubiquitin! removal! from! substrates! [21,! 23].! The! great! number! of!
enzymes,!

almost!

1000!

enzymes,!

which!

are!

associated!

with!

ubiquitination/deubiquitination! reactions! suggested! that! this! reversible! reaction!
has!a!significant!physiological!role.!Recently,!many!ubiquitinationStargeted!studies!
have!successfully!addressed!some!of!its!regulatory!functions,!such!as!regulation!
of! receptor! signaling! and! proteolysis! of! unwanted! proteins! through! ubiquitin!
proteasome!system!(UPS)![24,!25].!Apparently,!a!dysfunction!in!the!ubiquitination!
regulatory! roles! may! interfere! in! the! development! of! different! diseases! due! to!
abnormal!cell!signaling!or!degradation!of!essential!proteins![24S26].!!
1.2.2(Ubiquitin(Proteasome(System(
In!a!normal!state,!all!proteins,!intracellular!and!extracellular,!are!constantly!
subjected! to! a! process! called! “turn! over”! [27].! The! proteins! are! selectively!
degraded! in! a! timely! or! a! signalSinduced! manner! and! are! replaced! by! newly!
synthesized! proteins! in! an! accurately! balanced! rate.! Proteolysis! takes! place! in!
different! compartments! in! each! cell,! i.e.! cell! membrane,! cytosol,! lysosome,! and!
endoplasmic! reticulum! [28].! While! extracellular! proteins! are! degraded! via!
lysosomes! after! endocytosis,! the! breakdown! of! the! vast! majority! of! intracellular!
proteins! is! carried! out! by! the! action! of! ATPSdependent! ubiquitin! proteasome!

!
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system!(UPS)![27,!28].!The!UPS!is!composed!of!two!complementary!subsystems:!
(1)!Ubiquitination!system,!which!is!made!up!of!ubiquitinating!enzymes,!E1,!E2,!and!
E3,!which!tag!the!targeted!proteins!to!activate!the!proteolytic!processing,!and!!(2)!
Proteasome! system,! which! is! responsible! for! protein! degradation! into! smaller!
polypeptides!and!amino!acids![29].!The!ubiquitinSmarked!proteins!are!recognized!
and! degraded! by! the! 26S! proteasome.! The! 26S! proteasome! is! made! up! of! a!
central! subunit,! 20S! proteasome,! and! a! peripheral! regulatory! subunit,! 19S,! that!
precisely!select!the!ubiquitinated!substrate,!unfold!it,!and!translocate!it!to!the!20S!
subunit!where!the!proteolysis!takes!place![27,!29].!
!

UPS! has! many! crucial! homeostatic! functions! such! as! quality! control,!

regulation! of! cell! cycle,! and! activation! of! some! physiological! responses.! The!
misfolded!or!unfolded!proteins!that!result!from!mutations,!abnormal!synthesis,!and!
free!radicals!are!precisely!degraded!and!removed!from!the!cells!representing!the!
UPS! quality! control! role! [27].! For! example,! many! misfolded! proteins! in! the!
endoplasmic! reticulum! are! removed! to! the! cytoplasm! via! ubquitination! to! be!
processed!by!UPS.!!
!

Since!in!each!cell!cycle!phase!there!are!different!proteins!to!control!it,!these!

proteins!levels!are!essential!to!trigger!and!terminate!that!particular!phase.!UPS!
plays!a!major!role!in!the!regulation!of!cell!cycle!through!controlling!some!proteins!
levels.!For!instance,!UPS!induces!the!transition!from!metaphase!to!anaphase!by!
the!proteolysis!of!Cyclin!B,!a!cellScycle!regulatory!protein,!marking!the!end!of!cell!
mitosis![30].!
!

!

!
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Regarding!its!role!in!the!activation!of!immune!response,!UPS!acts!on!major!

histocompatibility! complex! (MHC)! class! I! to! develop! and! display! antigenic!
fragments! on! the! cell! surface! to! be! detected! by! CD8+! T! cells.! When! a! foreign!
fragment!is!detected,!the!displaying!cell!is!rapidly!killed!by!cytotoxic!T!cell![31].!
1.2.3(Druggability(of(the(UPS(
(

As!mentioned!previously,!the!20S!subunit!of!the!26S!proteasome!is!where!

the! proteins’! breakdown! is! carried! out! [27].! Unlike! other! proteases,! this! subunit!
ensures! that! nearly! every! peptide! bond! in! the! targeted! polypeptide,! except! the!
repeated!glutamine!sequence,!is!prone!to!degradation!due!to!the!multidimensional!
active!proteolytic!sites!in!this!subunit![32].!Many!different!research!projects!have!
been! carried! out! to! study! the! 20S! proteasome! genetically,! structurally,! and!
functionally.! In! general,! the! 20S! proteolysis! takes! place! specifically! after! a!
particular!amino!acid.!It!involves!three!different!classes!of!proteolytic!active!sites,!
six! catalytic! βSsubunits,! two! active! sites! degrade! the! polypeptide! after! the!
hydrophobic!amino!acids,!two!sites!breakdown!the!protein!after!the!acidic!amino!
acids,!and!two!act!on!the!bond!after!the!basic!amino!acids![29].!In!addition,!several!
functional!studies!have!successfully!proved!the!catalytic!role!of!the!NSterminal!Thr!
in!the!20S!proteasome!activity!and!found!that!mutations!of!the!NSterminal!threonine!
inactivate!this!subunit,!suggesting!the!major!role!that!the!Thr!residue!plays!in!the!
proteolysis! reaction! [33].! Accordingly,! further! studies! have! come! up! with! the!
proposed!mechanism!of!the!20S!proteasome!action:!(1)!The!(SOH)!group!of!the!NS
terminal!threonine!attacks!the!amide!group!of!the!targeted!peptide!bond!forming!a!
covalent! acylSenzyme! intermediate! with! transferring! the! (SOH)! proton! to! the!

!
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dissociated! (SNH)! group,! releasing! the! first! fragment.! (2)! Hydrolysis! of! the! acylS
enzyme!intermediate!occurs!to!reSform!a!free!enzyme!and!the!second!fragment!
[29,!33].!Since!this!mechanism!is!unique!for!the!20S!proteolysis,!many!molecules!
have!been!discovered!to!inhibit!this!process.!!
!

Bortezomib,!an!important!antineoplastic!medication,!is!one!of!the!synthetic!

UPS! inhibitors.! In! 2003,! this! drug! was! approved! by! US! FDA! to! treat! multiple!
myeloma!and!became!the!first!proteasome!inhibitionSbased!drug.!Its!mechanism!
of! action! generally! is! through! blocking! NFSκB! activation! [34].! NFSκB! is! a!
transcription!factor,!which!is!essential!for!cell!proliferation!and!cytokines!synthesis!
in! response! to! inflammations! and! was! found! persistently! active! in! cancer! cells!
displaying!antiSapoptotic!activity![35].!Moreover,!it!was!revealed!that!myeloma!cells!
depend! on! NFSκB! in! growth! factor! synthesis! [34,! 35].! Therefore,! due! to! the!
important! role! of! the! ubiquitin! proteasome! system! in! activation! of! NFSκB,!
Bortezomib!(Valcade!®)!induces!apoptosis!in!myeloma!cells![34].!
1.2.4(UPS(and(Insulin(Resistance(
!

InflammationSinduced! insulinSsignaling! disturbance! leads! to! insulin!

resistance,!which!is!one!of!the!manifested!characteristics!of!Type!II!diabetes![36,!
37].!Accordingly,!many!studies!have!shown!that!ubiquitination!plays!a!critical!role!
in!inflammationSmediated!insulin!resistance!development!in!mice![38].!A!chronic!
lowSgrade! inflammation! induces! the! abundant! formation! of! cytokines.! These!
cytokines!stimulate!the!expression!of!suppressors!of!cytokines!signaling!(SOCS)!
that!target!IRS1!to!initiate!its!ubiquitination!and!breakdown!by!UPS![38].!

!

!

!
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Normally,!PI3k/Akt!pathway!regulates!IRS1!via!its!dual!role,!positive!and!

negative!feedback![39].!A!downstream!messenger,!mechanistic!target!of!
rapamycin!(mTOR),!is!activated!by!the!action!of!protein!Ras!homolog!enriched!in!
brain!(Rheb)!that!is!stimulated!by!Akt!in!response!to!insulin!to!stimulate!protein!
synthesis![40].!mTOR!binds!to!and!activates!S6!kinase!(translation!factor)!that!
binds!to!the!large!subunit!of!ribosomes!and!triggers!the!translation!of!mRNA!into!
a!protein![40,!41].!A!study!has!shown!that!the!hyperactivated!mTOR!and!S6!
kinase!result!in!phosphorylation!of!specific!serine!residues!(SerS307/Ser312!and!
SerS527)!on!IRS1![41].!This!phosphorylation!promotes!the!binding!of!Ubiquitin!
ligaseS7!to!IRS1!to!be!degraded!by!UPS![41].!!

1.3(Skeletal(Muscle(in(T2D(Research(
As!mentioned!previously,!insulin!has!many!critical!metabolic!activities!such!
as! glucose! and! lipid! metabolism,! protein! synthesis,! and! regulation! of! gene!
expression![7].!And,!insulin!resistance!in!the!major!glucoseSconsuming!tissues!is!
involved!in!T2D!pathogenesis![6,!8,!10].!Accordingly,!obtaining!extensive!research!
studying! the! deviation! in! insulin! molecular! signaling! networks! during! the!
development!of!insulin!resistance!may!help!unveil!the!mysterious!mechanism!of!
T2D!pathogenesis.(
1.3.1(Proteomics(
After! the! impressive! results! of! the! human! genome! project! of! identifying!
almost! 20,000S25,000! genes! that! led! to! the! identification! of! many! diseaseS
associated! genetic! mutations,! a! relatively! new! phase! in! molecular! biology! has!

!

!

12!

been!established!to!study!structures!and!functions!of!the!resultant!proteins!of!each!
gene!to!understand/predict!their!role!in!the!development!of!different!diseases![42S
44].! Unlike! genome,! which! mostly! remains! unchanged! during! a! person’s! life,!
proteome!reflects!the!cellular!changes!in!a!particular!phase![42].!Consequently,!
proteome!provides!a!critical!tool!that!could!be!targeted!to!study!the!impact!of!a!
specific!endogenous!or!exogenous!factor!on!a!disease’s!development.!Many!novel!
discoveries!in!molecular!biology!have!been!concluded!through!comparing!different!
states!of!a!specific!cell,!i.e.,!studying!the!changes!in!a!cell!line!under!stress!and!
comparing!that!with!a!normal!state!cell!line.!In!proteomics,!scientists!also!study!the!
changes! of! a! specific! protein! posttranslational! modification,! proteinSprotein!
interactions,!and!a!particular!organelle!under!different!cellular!states![42].!This,!in!
turn,!could!result!in!many!clinical!benefits,!e.g.,!identifying!a!novel!molecule!that!
can!be!targeted!to!treat!a!particular!disease!and!recognizing!many!biomarkers!that!
indicate! the! progression! of! diseases! at! their! early! stages,! i.e.,! Type! II! Diabetes!
Mellitus![45].!Due!to!the!capability!of!proteomics!to!identify!and!quantify!hundreds!
of! proteins,! proteinSprotein! interactions,! and! protein! posttranslational!
modifications,!its!employment!to!diabetes!research!provides!a!promising!discipline!
to!unveil!the!pathophysiological!processes!behind!the!disease!progression!and!to!
identify!novel!pathways!that!could!be!targeted!in!drug!development.!
1.3.2(Skeletal(Muscle(Targeted(Proteomics(Research(
!

Many! research! projects! have! been! studying! the! posttranslational!

modifications! in! main! energy! storage! tissues! (e.g.,! liver,! adipose! tissue,! and!
skeletal!muscle).!However,!only!a!handful!of!them!are!focusing!on!skeletal!muscle,!

!
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which!is!responsible!for!the!uptake!of!nearly!80%!of!blood!glucose!in!response!to!
insulin! [46]! (Fig! 3).! This! represents! the! apparent! demand! of! skeletal! muscleS
targeted!research!studies.!In!addition,!the!significantly!accelerated!technological!
improvements! in! proteomicsSbased! research! have! generated! interesting!
information!on!posttranslational!modifications!that!are!unattainable!by!genomics!
approaches.!The!application!of!proteomics!to!human!skeletal!muscle!will!expand!
the!scientific!understanding!of!insulin!resistance!and!T2D!pathogenesis.!
1.3.3(HyperinsulinemicUEuglycemic(Clamp(
(

In!order!to!investigate!the!human!body!response!to!the!circulating!insulin!in#

vivo,!several!different!methods!have!been!invented.!The!most!widely!used!clinical!
methods!are!Oral!Glucose!Tolerance!Test,!Insulin!Tolerance!Test,!and!Glucose!
clamps![47].!In!1979,!Dr.!DeFronzo’s!group!developed!a!unique!method!that!has!
the! capability! to! test! the! tissues’! insulin! sensitivity! in! situ,! HyperinsulinemicS
Euglycemic!Clamp.!Basically,!this!method!includes!infusion!of!insulin!and!glucose!
into! the! human! body! according! to! the! participant’s! body! mass! index! (BMI)! and!
measuring! blood! glucose! in! constant! time! intervals! to! monitor! their! infusion!
accordingly! to! keep! the! blood! glucose! level! in! a! steady! state.! Any! change! in!
glucose!infusion!rate!is!represented!as!a!value!called!(MSvalue)!that!reflects!the!
body’s!sensitivity!to!insulin![48].!

1.4.(Mass(SpectrometryUBased(Proteomics(
!

Two! major! kinds! of! protein! information! can! be! obtained! from! proteomics!

experiments,! classical! and! functional! data.! Classical! data! provides! basic!

!
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information! about! the! protein! identity! and! abundance.! On! the! other! hand,!
functional! data! provides! more! information! about! the! protein! activity! and!
interactions! [49].! Accordingly,! several! techniques! can! be! used! in! proteomics! to!
quantify!and/or!characterize!proteins!such!as!twoSdimensional!gel!electrophoresis,!
multidimensional! protein! identification! technology,! protein! chips,! isotopeScoded!
affinity!tagging,!activitySbased!probe,!and!mass!spectrometry![49].!Each!method!
has! its! pros! and! cons.! For! instance,! using! twoSdimensional! gel! electrophoresis,!
researchers!can!detect!up!to!thousands!of!proteins!at!one!run.!However,!its!low!
sensitivity!to!the!low!abundance!proteins,!which!represent!about!50%!of!cellular!
proteins,!is!a!major!drawback![49].!Thus,!researchers!have!ranked!the!proteomics!
methods!according!to!many!factors:!the!sensitivity!to!low!abundance!proteins,!the!
ability!to!investigate!proteins!activities,!the!ability!to!detect!protein!interactions,!and!
the! method! speed! [49].! Only! a! few! methods! fulfill! all! these! characteristics.! The!
golden! method,! mass! spectrometry,! is! one! of! the! most! widely! used! methods! in!
proteomics!due!to!its!ability!to!detect!and!quantify!proteins!at!a!high!throughput!
fashion! [50].! The! extensive! technological! improvements! in! mass! spectrometry!
have!significantly!enhanced!proteomics!research![51].!!
In!this!present!study,!we!performed!the!first!largeSscale!differential!lysine!
ubiquitination!analysis!of!primary!skeletal!muscle!cells!derived!from!lean,!insulinS!
sensitive,! nonSdiabetic! participants! under! the! hyperinsulinemic! hyperglycemic!
condition.! ! Pan! ubiquitination! antibodies! were! used! to! quantify! overall! protein!
ubiquitination! under! low! glucose! no! insulin! or! high! glucose! and! high! insulin!
conditions.! Furthermore,! a! combination! of! ubiquitinatedSpeptide! enrichment!

!
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technique!and!the!UniversalSSILAC!approach!recently!developed!in!our!laboratory!
was!employed![52]!to!identify!and!quantify!siteSspecific!lysine!ubiquitination!sites!
under!these!conditions.!!!The!goal!of!the!study!is!to!determine!the!effect!of!the!
treatment! of! high! glucose! and! high! insulin! on! global! ubiquitination! in! insulinS
sensitive!primary!skeletal!muscle!cells.!
!

!

(
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CHAPTER(2(EXPERIMENTAL(DESIGN(

!

The! experimental! results! of! this! project! were! obtained! from! two!

complementary! studies,! clinical! research! and! benchSside! investigation! (Fig! 4).!
Human!clinical!research!was!carried!out!to!recruit,!screen,!assess,!and!classify!the!
participants.!Each!participant!was!scheduled!for!two!visits!to!the!Clinical!Research!
Center!at!Wayne!State!University.!In!addition!to!the!phone!screening!prior!to!the!
first! visit! (VS1),! a! comprehensive! assessment! was! performed! to! assign! the!
participants! to! the! corresponding! classes! and! to! confirm! their! eligibility! to! be!
included!in!the!study.!After!the!confirmation!of!the!participants’!eligibility,!they!were!
scheduled! for! a! second! visit! (VS2)! to! perform! the! hyperinsulinemicSeuglycemic!
clamp!and!collect!the!skeletal!muscle!biopsies!(Fig!5).!Then,!the!obtained!muscle!
biopsies! were! sent! to! the! laboratory! to! conduct! the! proteomics! investigations.!
Basically,! the! proteomics! study! workflow! was! as! follow:! skeletal! muscle! cell!
culture,!cell!collection,!cell!homogenization,!inSsolution!trypsin!digestion,!desalting!
and!peptide!extraction,!ubiquitinated!peptide!enrichment,!and!HPLCSESISMS/MS!
analysis.! Afterwards,! molecular! pathway! and! functional! assessment! were!
performed! using! bioinformatics! analysis! and! literature! search! to! interpret! the!
proteomic!data.!

2.1.(Materials(
2.1.1(Antibodies(
!

We! purchased! a! PTMScan®! Pilot! Ubiquitin! Remnant! Motif! (KSeSGG)! Kit!

(from!Cell!Signaling!Technologyq!Catalogue!number:!14482S)!containing!Ubiquitin!
!

!
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monoclonal! antiSdiglycine! Remnant! (KSεSGG)! antibody,! IAP! buffer,! and! trypsin!
digested!control!peptides!for!immunoprecipitation.!For!western!blot,!we!purchased!
AntiSUbiquitin! antibody! (Abcamq! Catalogue! number:! ab7780)! containing! Rabbit!
polyclonal!to!Ubiquitin.!The!secondary!antibody!was!AntiSrabbit!IgG,!peroxidaseS
linked!speciesSspecific!whole!antibody!from!donkey.!!
2.1.2(Reagents(
(

In! this! study,! the! following! supplies! were! purchased:! MS! Grade! Trypsin!

protease!(Fisher!scientificq!Catalogue!numbers:!90057!and!90058)q!iodoacetamide!
(Sigma,! St! Louis,! MOq! Catalogue! number:! I1149S5G)q! C18! ZipTip! (Millipore,!
Billerica,! MA)q! Alltech™! ReversedSPhase! ExtractSClean™! Columns! (High!
Capacity!C18q!500mgq!8Ml,!High!capacity!CS18q!Column!size:!1.5mLq!Bed!weight:!
100mgq! Fisher! scientificq! Catalogue! numbers:! AT255350! and! AT255100,!
respectively)q!Insulin!ELISA!Jumbo!(AlPCO,!Salem,!NH,!Catalogue!number:!80S
INSHUSE10.1)q! and! IAP! buffer! (PTMScan®! IAP! Buffer! (10X)q! Cell! Signalingq!
Catalogue!number:!9993S)(

2.2(Subjects(
(

Four!lean,!healthy!participants!were!enrolled!in!the!study!at!the!C.!S.!Mott!

Clinical! Research! Center! at! Wayne! State! University.! The! purpose,! procedures,!
and! the! possible! risks! of! the! study! were! described! to! all! volunteers,! and! their!
agreement!to!take!part!in!the!study!was!obtained!in!the!form!of!a!written!consent!
prior! to! their! involvement! in! the! study.! Primary! screening,! including! vital! signs,!
ECG,! bioimpedance,! and! urine! analysis,! was! done! on! the! same! day! when! the!

!
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written!consent!was!obtained.!In!addition,!participants’!fasting!blood!glucose!levels!
were! measured! and! an! oral! glucose! tolerance! test! (OGTT)! was! performed! to!
measure! their! ability! to! tolerate! a! 75! g! glucose! drink! and! to! assign! them! to! the!
corresponding! class,! either! healthy! or! insulin! resistant.! None! of! the! participants!
was!involved!in!any!form!of!intense!exercise.!The!study!protocol!was!approved!by!
the!Institutional!Review!Board!of!Wayne!State!University.!!

2.3(HyperinsulinemicUEuglycemic(Clamp(with(Muscle(Biopsies(
!

Insulin!sensitivity!was!assessed!using!hyperinsulinemicSeuglycemic!clamp,!

and!skeletal!muscle!was!exposed!to!insulin!in!vivo,!as!previously!described![53,!
54].!On!the!day!of!the!2nd!visit,!the!participants!came!in!at!approximately!08:15!
a.m.,! after! a! minimum! of! a! 10Shour! overnight! fast,! and! their! vital! signs! were!
measured.!Then,!at!approximately!08:30!a.m.!(time!S60!min)!the!study!began!with!
placing!a!catheter!in!an!antecubital!vein.!This!catheter!was!maintained!throughout!
the! study! for! insulin! and! glucose! infusions.! A! second! catheter! for! sampling! of!
arterialized!venous!blood!was!placed!in!a!vein!in!the!contralateral!arm.!Baseline!
blood! samples! were! drawn! for! plasma! glucose! and! insulin! concentrations!
determination.! At! 09:00! a.m.! (time! S30! min)! under! local! anesthesia! using!
Lidocaine,! a! biopsy! was! obtained! from! the! vastus! lateralis! muscle! using! a!
percutaneous! needle! [55].! Protease! inhibitors! were! immediately! added! to! the!
extracted! muscle! biopsy! that! were! cleaned! from! connective! tissue! and! fat! (~30!
sec),! and! muscle! biopsy! was! immediately! transferred! in! iceScold! PBS! to! the!
laboratory!to!extract!skeletal!muscle!cells!thorough!a!process!called!primary!cell!

!
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culture.! At! 09:30! a.m.! (time! 0! min),! at! a! rate! of! 80! mU/m2/min,! a! continuous!
infusion!of!human!regular!insulin!(Humulin!Rq!Eli!Lilly,!Indianapolis,!IN)!was!started,!
and!continued!for!2!hrs.!Plasma!glucose!level!was!measured!at!5Smin!intervals!
and! monitored! throughout! the! clamp! to! maintain! euglycemia,! ~90! mg/dL,! by!
variable!infusion!of!DSglucose.!!

2.4(Plasma(Insulin(Concentration(Determination(
!

Plasma!insulin!level!was!measured!using!the!ALPCO!Insulin!ELISA!Jumbo.!

2.5(Proteomics(Sample(Preparation(and(Analysis(
2.5.1(Muscle(Cells(Processing(and(Protein(Measurement(
(

The! extracted! skeletal! muscle! cells! were! maintained! to! reach! 70S80%!

confluence!for!each!experimental!condition!in!150!mm!culture!dishes.!Then,!the!
myoblasts! were! fused! into! multiSnucleated! fibers,! myotubes,! through! a! process!
called! differentiation.! During! differentiation,! each! cell! line! was! divided! into! 4!
conditions:!(1)!Low!glucose!(1!g/L)!without!insulin!stimulation,!LGNI_BASq!(2)!Low!
glucose!(1!g/L)!with!insulin!stimulation!(100!nM)!for!15!min!after!4!hrs!starvation,!
LGNI_INSq!(3)!High!glucose!(4.5!g/L)!/High!insulin!(100nM)!for!2!days!without!15!
min! insulin! stimulation,! HGHI_BASq! (4)! High! glucose! (4.5! g/L)! /High! insulin!
(100nM)! for! 2! days! with! 15! min! insulin! (100! nM)! stimulation! after! starvation,!
HGHI_INS.! ! All! cells! were! washed! with! iceScold! PBS! 3! times! before! harvesting!
them.!All!dishes!from!each!condition!were!harvested!using!the!same!amount!of!
iceScold! lysis! buffer! A! (50! mmol/l! Hepes,! pH! 7.6,! 150! mmol/l! NaCl,! 20! mmol/l!

!
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Na4P2O7,! 20! mmol/l! βSglycerophosphate,! 10! mmol/l! NaF,! 2! mmol/l! sodium!
vanadate,!2!mmol/l!EDTA,!1%!Triton,!10%!glycerol,!1!mmol/l!phenylmethylsulfonyl!
fluoride! (PMSF),! 1! mmol/l! MgCl2,! 1! mmol/l! CaCl2,! 10μg/ml! leupeptin,! 10μg/ml!
aprotinin)!and!a!scraper.!After!that,!all!cell!lysates!were!homogenized!using!a!Next!
Advance!Bullet!Blender!(Model!BBY5E)!at!4°C!until!no!visible!contents!remained!
(~4×5min).!The!lysates!were!cleared!by!centrifugation!at!20,000!rcf!(g)!for!15!min!
at! 15°C! or! room! temperature! and! the! protein! extracts! (supernatants)! were!
transferred! into! new! tubes.! Protein! concentrations! in! the! supernatant! samples!
were! measured! by! the! Bradford! protein! assay! (Nanodrop! 2000c!
spectrophotometerq!Thermo!Scientific).!A!small!volume!of!the!lysates!was!saved!
to!perform!western!blot,!and!SILAC!lysates!were!added!in!a!ratio!of!1:4!to!every!
condition’s!lysate!that!underwent!immunoprecipitation.!
2.5.2(Western(Blot((
!

To!detect!the!level!of!protein!ubiquitination!among!all!conditions,!whole!cell!

lysates!prepared!from!human!skeletal!muscle!cell!lines!were!loaded!and!the!gels!
were! run! under! denaturing! conditions.! 5%! milk! in! TBSSTween! was! used! for!
blocking.!AntiSUbiquitin!antibodies!were!used!at!a!1/1000!dilution,!incubated!for!16!
hours!at!4°C!in!5%!milk!in!TBST.!The!secondary!antibody!was!peroxidaseSlinked!
speciesSspecific!whole!antibody!donkey!antiSrabbit!IgG,!used!at!a!1/10,000!dilution!
in!!5%!milk!in!TBST!for!1!hr!at!RT.!Immunoreactive!bands!were!detected!according!
to! their! chemiluminescence! and! the! bands! intensities! were! quantified! using! the!
ImageJ!software!(http://imagej.nih.gov/ij/).!

!
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2.5.3(Immunoprecipitation(
2.5.3.1&Reduction&and&Alkylation&of&Proteins&
(

1/278!volume!of!1.25!M!DTT!was!added!to!the!extracted!proteins!from!each!

condition,!mixed!well,!and!the!tubes!were!placed!into!a!55°C!incubator!for!30!min.!
The!solutions!were!cooled!on!ice!briefly!until!they!had!reached!room!temperature.!
1/10!volume!of!1M!iodoacetamide!solutions!were!added!to!the!protein!extracts,!
mixed!well,!and!incubated!for!15!min!at!room!temperature!in!the!dark.!Then,!the!
fractions!were!subjected!to!ultracel!10k!filters!to!purify!the!denatured!proteins!from!
salts.!
2.5.3.2&Trypsin&Digestion&and&Peptide&Purification&
!

1/50! volume! of! 1! mg/ml! trypsin! in! 40! mM! NH4HCO3! was! added! to! the!

samples!and!incubated!overnight!at!room!temperature!with!mixing.!The!digested!
peptides!were!acidified!with!1/20!volume!of!20%!TFA!to!the!peptides!for!a!final!
concentration!of!1%!TFA!before!loading!them!on!the!SepSPak!C18!columns!for!
desalting.!The!samples!were!placed!on!ice!for!15!min.!After!centrifugation!for!15!
min,! the! acidified! digested! peptides! were! loaded! to! the! columns! that! were!
prewashed!with!(1x!100%!ACN!and!3x!0.1%!TFA).!The!samples!were!washed!3x!
0.1!TFA!and!1x!5%!ACN/0.1%!TFA.!They!were!collected!after!elution!with!40%!
ACN/0.1%!TFA.!The!purified!samples!were!subjected!to!SpeedVac!to!remove!the!
solvents.!
!

The! beads! were! washed! four! times! with! PBS,! and! the! samples! were!

resuspended! in! 1.4! ml! IAP! buffer! and! pH! was! adjusted! to! pH=7.8! before!
centrifugation! at! 10,000! rcf! (g)! for! 5! min! at! 4°C.! Then,! the! peptides! were!
!

!
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transferred!into!the!beadScontaining!tubes!and!incubated!for!2!hours!on!a!rotator!
at!4°C.!The!beadSbound!peptides!were!washed!with!IAP!buffer!and!HPLCSgrade!
water!before!elution!with!0.15%!TFA!three!times.!The!eluates!were!dried!off!by!
vacuum! centrifugation! and! reconstituted! in! 0.1%! TFA! for! HPLCSESISMS/MS!
analysis.!
2.5.3.3&Mass&Spectrometry&
!

The!peptide!mixture!was!separated!with!a!linear!gradient!of!5S35%!buffer!B!

(100%!ACN!and!0.1%!FA)!in!180!minutes!at!a!flow!rate!of!250!nL/min!on!a!C18S
reversed!phase!column!(75µm!ID,!15!cm!length)!packed!inShouse!with!ReproSilS
Pur! C18SAQ! µm! resin! (Dr.! Maisch! GmbH)! in! buffer! A! (0.1%! FA).! A! nanoflow!
Ultimate! 3000! RSLCnano! system! (Thermo! Scientific)! was! onSline! coupled! to! a!
Thermo! Finnigan! LTQSOrbitrap! Elite! fitted! with! a! nanospray! flex! Ion! source!
(Thermo!Fisher,!San!Jose,!CA).!MS!data!were!acquired!in!a!“TopS20SRCID”!dataS
dependent! strategy! selecting! the! fragmentation! events! based! on! the! precursor!
abundance!in!the!survey!scan!(400S1650!Th).!
2.5.4(Data(Analysis(
Peptides/protein!identification!and!quantification!were!performed!using!the!
MaxQuant,!one!of!the!popular!quantitative!proteomics!software!packages![56,!57].!!
Briefly,!raw!MS!files!were!processed!using!the!MaxQuant!(ver.1.3.0.5)!against!a!
database! with! forward! and! reversed! Uniprot! Human! protein! sequences,!
downloaded! from! www.uniprot.org.! ! Standard! settings! in! the! MaxQuant! were!
applied.!!Parent!mass!tolerance!was!5!p.p.m.,!and!fragment!mass!tolerance!was!
0.5!Da.!Four!missing!trypsin!cleavage!site!was!allowed,!carbamidomethylation!was!
!
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searched! as! a! fixed! modification,! and! lysine! ubiquitination! (as! reflected! by! GGS
lysine),!methionine!oxidation!(Mox),!phosphorylation!(STY),!Acetylation!(Protein!NS
term),!isotopeSlabeled!lysine!(+4.00!Da)!and!isotopeSlabeled!arginine!(+10.00!Da)!
were!allowed!as!a!variable!modification.!The!FDR!for!both!proteins!and!peptides!
(with! minimum! 6! amino! acids)! was! set! to! 0.01.! ! Only! ubiqutination! sites! with! a!
localization!probability!greater!than!0.75![58,!59])!were!considered.!
To!minimize!the!experimental!variation!during!sample!preparation!and!HPLCS
ESISMS/MS!data!acquisition,!we!developed!and!validated!a!modified!SuperSSILAC!
approach,! in! which! SILACSlabeled! protein! lysates! were! spikedSin! to! each!
experimental! sample! and! were! used! as! a! universal! standard! for! quantification!
purposes![52].!This!modified!SuperSSILAC!approach!(we!now!term!it!as!UniversalS
SILAC)!provides!quantitative!information!for!more!phosphorylation!sites!than!the!
traditional! SuperSSILAC! quantification.! Using! this! approach,! we! identified! 3876!
phosphorylation! sites! (620! were! novel),! and! found! that! knockdown! of! Protein!
phosphatase! 1! regulatory! subunit! 12A! in! L6! cells! resulted! in! increased! overall!
phosphorylation!in!L6!cells!at!the!basal!condition,!and!changed!phosphorylation!
levels!for!698!sites!(assigned!to!295!phosphoproteins)!at!the!basal!and/or!insulinS
stimulated!conditions![52].!!In!the!present!study,!we!applied!UniversalSSILAC!to!
the!quantification!of!the!ubiquitination!in!primary!skeletal!muscle!cells!derived!from!
lean!healthy!human!participants!in!the!absence!and!presence!of!high!glucose/high!
insulin! treatment,! and( calculated! the! modified! SILAC! ratio! as! described! in! our!
manuscript! [52]:! an! individual! peak! area! for! a! ubiquitination! site! (PAi)! was!

!
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normalized!against!the!sum!of!the!peak!area!for!the!heavy!labeled!ubiquitination!
sites!in!the!same!sample:!
Norm: & =
!

PA&
,,!
Sum,of,the,peak,area,for,the,heavy,labeled,ubiquitination,sites,

The!normalized!peak!area!(i.e.,!modified!SILAC!ratio)!for!each!ubiquitination!

site! was! log2! transformed! and! compared! to! assess! effects! of! acute! insulin! or!
relatively! longSterm! high! glucose/high! insulin! treatment! on! ubiquitination! levels!
among!the!4!sets!of!samples!(LGNI_BAS,!LGNI_INS,!HGHI_BAS,!and!HGHI_INS)!
of!primary!skeletal!muscle!cells!derived!from!muscle!biopsies!from!4!lean!insulinS
sensitive!human!participants.!
2.5.5(Statistical(Analysis(
Although! a! large! number! of! ubiquitination! sites! were! assigned! in! at! least!
one!of!the!16!samples!that!were!studied,!a!series!of!filters!were!used!to!narrow!the!
number! of! ubiquitination! sites! that! were! used! in! comparisons! among! groups! as!
described!in!Figure!11.!!!Statistical!significance!was!assessed!using!paired!t!tests.!
Differences!were!considered!statistically!significant!at!p<0.05.!
2.5.6(Bioinformatics(Analysis(
Pathway!analysis!was!performed!using!DAVID!(Database!for!Annotation,!
Visualization!and!Integrated!Discovery)!(https://david.ncifcrf.gov/),!which!assigns!
each! identified! gene! to! its! corresponding! biological! process.! DAVID! is! a! webS
accessible! database! that! provides! an! extensive! functional! annotation! tool! to! a!

!
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gene! list.! A! pathway! was! considered! as! significantly! enriched! if! pSvalue! <! 0.01!
(See!Fig!12!and!Table!2).!

!
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CHAPTER(3(RESULTS(

The!clinical!information!of!participants!involved!in!the!project!is!shown!in!
Table!1.!Criteria!classifying!the!state!of!diabetes!are!shown!in!the!table,!namely!
2h!OGTT!Glucose!level,!HBA1c!percentage,!and!Fasting!plasma!glucose!level,!
manifesting!the!values!within!healthy,!nonSdiabetes!range.!!
Hyperinsulinemia!and!hyperglycemia!are!known!to!have!unfavorable!effects!
on!many!cells!types![60].!To!understand!the!effect!of!the!high!glucose/high!insulin!
condition! on! the! skeletal! muscle! system,! the! levels! of! proteins! ubiquitination! in!
human!skeletal!muscle!cells!was!evaluated!under!low!and!high!concentrations.!In!
addition,! the! impact! of! an! acute! 15Sminute! insulin! treatment! (after! serum!
starvation)!on!the!ubiquitination!pattern!was!investigated.!

3.1.(Total(Ubiquitination(in(Primary(Human(Skeletal(Muscle(Cells(under(
Hyperinsulinemic(Hyperglycemic(Conditions(
First,!the!effect!of!hyperglycemia!on!the!total!protein!conjugation!to!ubiquitin!
moieties!in!skeletal!muscle!cells!was!examined.!The!cells!were!incubated!with!low!
glucose/no!insulin!(LGNI)!or!high!glucose/high!insulin!(HGHI)!culture!media!for!48!
h,!and!then!the!average!intensities!of!total!ubiquitinated!proteins!in!each!cell!line!
were!measured.!!
Bands!in!Fig.!6!show!that!HGHI!treatment!caused!a!significant!decrease!
(fold!change!0.72!±!0.058!vs.!LG,!P!<!0.05)!in!total!protein!ubiquitination!compared!
to!LGNI!treated!cells.!!
Next,! whether! the! exposure! of! skeletal! muscle! cells! to! acute! 15Sminute!
insulin!treatment!affects!the!reduction!pattern!of!total!ubiquitinated!proteins!level!
!
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with! hyperglycemiaSHyperinsulinemia! was! assessed.! As! shown! in! Fig.! 7,! the!
reduction! in! total! proteins! ubiquitination! with! HGHI! treatment! was! significantly!
decreased!(fold!change!0.71!±!0.056!vs.!LG,!P!<!0.01)!compared!to!LGNI!treated!
cells.! This! suggests! that! insulin! does! not! change! the! marked! reduction! in! total!
protein!ubiquitination!after!2Sday!HGHI!treatment.!!
Furthermore,!the!15SminuteSinsulinSstimulated!cells!were!normalized!to!their!
corresponding!basal!cells!to!investigate!the!effect!of!insulin!stimulation!on!the!total!
conjugation! of! human! skeletal! muscle! proteins! to! ubiquitin.! As! shown! in! Fig.! 8,!
there!is!no!effect!for!15Sminute!insulin!stimulation!on!the!total!ubiquitination!level!
in!skeletal!muscle!cells!treated!with!HGHI.!
Next,!the!effect!of!HGHI!treatment!on!individual!bands!shown!in!Fig.!6!was!
examined,!separately.!!Fig.!9.A!shows!a!significant!reduction!in!the!ubiquitination!
level! in! the! proteins! with! molecular! weight! around! 75! KD! in! the! case! of!
hyperglycemiaShyperinsulinemia!(fold!change!0.68!±!0.06!vs.!LG,!P!<!0.05).!After!
insulin! stimulation! (Fig.! 9.B),! fold! change! was! similar! (0.75! ±! 0.05! vs.! LG,! P! <!
0.005).!!!Similar!to!the!total!ubiquitination,!Fig.!9.C!shows!no!effect!for!15Sminute!
insulin!stimulation!on!the!accumulation!of!ubiquitinated!proteins!in!the!75!KD!band!
with!HGHI!treatment.!!
Moreover,! as! shown! above! in! Fig.! 10,! the! abundance! of! ubiquitinated!
proteins! in! 50KD! and! 37KD! bands! was! not! different! between! LGNI! and! HGHI!
treated!cells!except!for!ubiquitinated!proteins!in!50KD!band!upon!15Sminute!insulin!
stimulation!(Fig.!10.B,!fold!change!0.50!±!0.09!vs.!LG,!P!<!0.05).!!
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3.2.(SiteUSpecific(Ubiquitination(in(Primary(Human(Skeletal(Muscle(Cells(
under(Hyperinsulinemic(Hyperglycemic(Conditions((
In! order! to! identify! the! changes! in! siteSspecific! ubiquitination,! ubiquitin!
remnant!motif!(KSεSGG)!antibodies!were!used!to!enrich!ubiquitinated!peptides!from!
all! 4! skeletal! muscle! primary! cell! cultures! used! for! the! study.! In! total,! 339!
ubiquitination!sites!assigned!to!171!proteins!were!detected.!Among!the!339!sites,!
110!sites!were!identified!in!more!than!half!of!the!samples.!21!out!of!the!110!sites!
showed! significant! change! in! their! ubiquitination! in! the! 4! sets! of! samples!
(LGNI_BAS,! LGNI_INS,! HGHI_BAS,! and! HGHI_INS).! Out! of! these! 21! sites,! 5!
were!previously!unreported!in!human.!Please!see!(See!Fig!13!ASU!and!Table!3!for!
details)!!
DAVID!analysis!of!the!ubiquitination!sites!indicated!that!multiple!biological!
processes! are! significantly! enriched,! such! as! pathways! related! to! interleukinS1!
receptorSassociated!kinase!1,!regulation!of!activated!PAKS2p34,!protein!synthesis!
and!degradation,!and!cytoskeleton!dynamics!(Fig!12!and!Table!2).!These!results!
imply!that!ubiquitination!participates!in!regulation!of!these!biological!processes.!
Furthermore,! as! mentioned! above,! we! have! observed! a! significant!
reduction! in! ubiquitinated! protein! level! at! the! 75! KD! band! using! WB! (Figure! 6).!
Combining! the! WB! results! with! the! IP! data,! we! identified! 21! candidate! proteins!
with!molecular!weight!around!75!KD!after!ubiquitination!based!on!the!number!of!
possible!ubiquitination!sites!in!each!protein.!Additional!experiments!are!warranted!
to!determine!which!of!these!21!proteins!contribute!to!the!decreased!ubiquitination!
in!the!75!KD!bands!upon!HGHI!treatment.!!

!
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CHAPTER(4(DISCUSSION(

Recently,! genomics! along! with! transcriptomics! studies! have! unveiled!
valuable! information! regarding! mechanisms! underlying! insulin! resistance! and!
T2D.!However,!the!abnormalities!in!protein!posttranslational!modifications!may!not!
be! investigated! using! genomics! and! transcriptomics! [61].! Mass! spectrometryS
based! proteomics! has! emerged! as! a! powerful! method! for! investigating! protein!
postStranslational! modification! in! the! development! of! insulin! resistance.!
Ubiquitination! along! with! phosphorylation! represents! a! crucial! regulatory!
modification! that! controls! intracellular! signaling! [62].! However,! no! ubquitinome!
study!in!primary!human!skeletal!muscle!cells!has!been!reported!yet.!The!present!
project!determined!overall!ubiquitination!and!siteSspecific!ubiquitination!in!skeletal!
muscle!primary!cells!derived!from!4!lean!healthy!participants!using!immunoblotting!
technique!and!Mass!spectrometrySbased!proteomics!approach,!respectively.!The!
immunoblotting! technique! includes! using! antiSubiquitin! polyclonal! antibody! to!
detect!the!ubiquitination!level!change!in!the!cells!under!different!conditions.!On!the!
other! hand,! the! proteomics! approach! includes! ubiquitin! remnant! motif! (KSεSGG)!
immunoprecipitation!followed!by!HPLCSESISMS/MS.!Using!this!strategy,!we!have!
identified!21!ubiquitination!sites!that!are!significantly!changed!among!the!4!sets!of!
samples!(LGNI_BAS,!LGNI_INS,!HGHI_BAS,!and!HGHI_INS).!The!involvement!
of!these!sites!in!multiple!functional!pathways!in!skeletal!muscle!cells!is!discussed!
below!(See!Fig!13!ASU!and!Table!3!for!more!details).!

!
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4.1.(Total(Ubiquitination(in(Primary(Human(Skeletal(Muscle(Cells(under(
Hyperinsulinemic(Hyperglycemic(Conditions((
In!this!study,!we!have!expanded!the!findings!of!physiological!changes!in!
primary! human! skeletal! muscle! cells! under! different! glucose/insulin!
concentrations.! Although! insulin! involvement! in! the! regulation! of! protein!
degradation!was!reported!previously![63,!64],!its!impact!on!ubiquitinSproteasome!
system!in!different!cells!remains!unclear.!!!
In!HepG2!and!red!blood!cells,!insulin!showed!a!significant!inhibitory!effect!
on! UPS! activity! through! blocking! the! proteasomal! degradation! of! ubiquitinated!
proteins!and!further!increased!the!accumulation!of!ubiquitin!conjugates![65].!!In!
contrast,! we! did! not! observe! increased! total! ubiquitination! in! primary! human!
skeletal!muscle!cells,!suggesting!insulin!affects!ubiquitination!in!a!tissue/cellStype!
specific!manner.!!
Interestingly,!we!observed!a!significant!reduction!in!the!total!ubiquitinated!
proteins! in! cases! of! hyperglycemia! and! hyperinsulinemia! in! primary! human!
skeletal!muscle!cells!(Fig!6S10).!One!possible!explanation!is!that!hyperglycemia!
and!hyperinsulinemia!increase!the!activity!of!deSubiquitination!enzymes.!!

4.2(SiteUSpecific(Ubiquitination(in(Primary(Human(Skeletal(Muscle(Cells(
under(Hyperinsulinemic(Hyperglycemic(Conditions(
4.2.1(ACTA1 (
αSactin!is!a!member!of!the!actin!family!that!also!includes!β–!and!γSactin.!It!
is!a!highly!conserved!protein!that!forms!a!major!part!of!the!cytoskeleton.!Within!
the! myocytes,! actin! along! with! myosin! forms! the! sarcomere,! which! is! the!
contractile! structure! in! muscles.! Also,! they! are! important! in! maintaining! the!

!
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structural! framework! of! the! muscle! cells,! the! cytoskeleton.! Recent! studies!
suggested!that!insulin!receptor!signaling!is!important!for!the!development!of!actin!
organization!in!neuronal!cells!through!insulinSPI3KSAkt!or!DHASAkt!pathways![66].!
In! this! study,! we! showed! that! the! ubiquitinSconjugation! with! αSactin! at! K193( is!
reduced!upon!15Sminute!insulin!stimulation!(Fig.!13A).!This!result!suggests!that!
ubiquitinSdependent!degradation!is!a!part!of!insulin!regulation!of!actin.!
4.2.2(ANTXR1(
ANTXR1,! which! is! a! coding! gene! for! a! protein! named! as! Anthrax! toxin!
receptor! 1,! showed! a! decreased! ubiquitination! at! K453! with! hyperinsulinemiaS
hyperglycemia! under! after! 15Sminute! insulin! stimulation! (Fig.! 13B).! This! protein!
has!a!major!role!in!cell!adhesion!and!migration!via!its!binding!to!extracellular!matrix!
proteins,!and!it!facilitates!cells!attachment!to!type!1!collagen!and!gelatin!and!cell!
spreading.! Moreover,! Anthrax! toxin! receptor! 1! is! important! for! angiogenesis.! A!
recent! study! showed! that! upon! ANXTR1! blockade,! tumor! cells! become! more!
responsive! to! antineoplastic! agents! and! there! is! a! reduction! in! patient! mortality!
[67].!
4.2.3(CCDC50(
CoiledScoil! domainScontaining! protein! 50,! also! known! as! Ymer,! is! a!
cytoplasmic,! soluble! protein! that! has! several! ubiquitination! sites.! This! protein! is!
involved!in!the!regulation!of!many!pathways!as!a!positive!or!negative!regulator.!As!
a!negative!regulator,!it!is!involved!in!NFSκB!signaling.!During!the!beginning!stages!
of! TNFSReceptorS1! signaling,! ubiquitination! takes! place! in! ReceptorSinteracting!
protein! 1! (RIPS1)! to! activate! IKSkinase! and! NFSκB.! IKSkinase! inactivates! the! deS
!
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ubiquitinase!enzyme!(Cylindromatosis)!via!phosphorylation.!Then,!NFSκB!induces!
the!overSexpression!of!proteins!A20!and!IκBα!and!serves!as!a!negative!feedback.!
Therefore,! A20! binds! to! many! proteins,! including! YMER,! to! induce! RIP1!
degradation.! In! contrast! to! its! role! in! NFSκB! signaling,! YMER! facilitates! JNK!
phosphorylation! as! a! positive! regulator! in! this! pathway! [68].! The! ubiquitinS
conjugation! with! CCDC50! at! lysine! 152( was! significantly! increased! with! low!
glucose/no!insulin!condition!after!15!min!insulin!stimulation!(Fig.!13C).!
4.2.4(DAGU1(
In!normal!muscle,!dystroglycan!forms!a!complex!to!stabilize!the!connection!
between! the! cytoskeleton! and! the! extracellular! matrix.! A! downregulation! of!
dystroglycan! in! skeletal! muscle! may! be! involved! in! the! muscle! fiber! weakness,!
sarcolemmal!signaling!disruption!and/or!cytoprotective!mechanism!disturbance!in!
diabetics.!Studies!suggested!that!insulin!effect!in!diabetic!skeletal!muscle!might!
be!altered!due!to!impaired!sarcolemmal!signaling!with!GLUT4!transporters,!which!
might!be!a!key!step!in!the!development!of!skeletal!muscle!insulin!resistance![69].!
We!observed!a!significant!change!in!the!ubiquitination!of!lysine!794!in!this!protein!
upon!different!treatment!conditions!(Fig.!13D).!
4.2.5(EPNU1(
Epsin! is! a! protein! that! is! detected! in! cytoplasm,! cell! membrane,! and!
nucleus.!It!is!necessary!in!controlling!the!activity!of!the!epidermal!sodium!channel,!
which!regulates!sodium!and!water!reabsorption!at!the!cell!surface![70].!Also,!it!is!
involved!in!the!EGFR!signaling!pathway,!and!studies!showed!that!epsinS1!is!critical!
for! EGFR! endocytosis! [71].! It! facilitates! the! trafficking! of! ubiquitinated! EGFR!
!
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across! the! cell! membrane.! This! study! showed! a! significant! reduction! in! the!
ubiquitin!binding!to(K107!under!different!conditions!(Fig.!13E).!
4.2.6(ERH(
The!enhancer!of!rudimentary!homolog!is!a!highly!conserved!protein!that!is!
involved!in!transcription!and!cell!cycle!regulation.!Many!studies!showed!a!critical!
role! for! ERH! in! mitosis! and! genomic! stability! [72].! In! this! study,! there! was! a!
significant!increase!in!ubiquitination!at!lysine!12(with!hyperglycemia!(Fig.!13F).!
4.2.7(ITM2B(
ITM2B! belongs! to! the! BclS2! family! that! has! a! crucial! role! in! apoptotic!
processes! by! regulating! the! outer! mitochondrial! membrane! permeability.! This!
family!is!composed!of!antiSapoptotic!and!proSapoptotic!members.!ITM2B!is!one!of!
the!proSapoptotic!proteins!that!are!induced!by!ILS2!deprivation!in!T!lymphocytes!
undergoing!apoptosis![73].!We!observed!a!significant!reduction!in!ubiquitination!of!
K13!with!hyperglycemicShyperinsulinemic!condition!after!insulin!stimulation!(Fig.!
13H).!
4.2.8(SPG20((
Spartin! is! a! mitochondrial! protein! that! contains! a! domain! of! microtubule!
interacting! and! trafficking! molecule! (MIT).! Spartin! activity! is! controlled! by!
ubiquitination/deSubiquitination.!This!protein!is!involved!in!regulating!mitochondrial!
functions!and!endocytosis.!Recent!studies!have!shown!an!important!mechanism!
for!SPG20!in!the!regulation!of!lipid!molecules’!turnover![74].!Ubiquitination!of!lysine!
362! was! significantly! increased! with! hyperinsulinemicShyperglycemic! condition!
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(Fig.!13M).!
4.2.9(VCP(
VCP,!also!known!as!transitional!endoplasmic!reticulum!ATPase,!is!involved!
in! the! assembly! of! Golgi! stacks! during! mitosis.! It! also! plays! a! major! role! in! the!
transfer! of! membranes! from! the! endoplasmic! reticulum! to! the! Golgi! apparatus.!
Transitional! endoplasmic! reticulum! ATPase! drives! misfoldedSubiquitinated!
proteins!from!the!ER!to!the!cytoplasm,!for!the!proteasomal!degradation![75].!In!this!
study,! ubiquitin! binding! to! K668! was! increased! with! hyperglycemiaS
hyperinsulinemia!(Fig.!13O).!
4.2.10(Ribosomal(subunits:(
Although! ubiquitination! has! been! recognized! as! a! critical! regulatory!
modification!in!many!biological!processes,!its!activity!was!mostly!known!for!protein!
degradation.! ! With! the! increased! awareness! about! ubiquitination’s! role,! it! was!
reported! that! ubiquitin! conjugation! to! some! molecules! has! a! key! role! in! their!
activation.!Ubiquitin!attachment!to!ribosomes,!which!have!been!well!defined!as!the!
large! molecular! machineries! for! protein! synthesis,! in! a! cellScycle! dependent!
manner!results!in!improved!ribosomal!efficiency!in!protein!synthesis![76].!In!this!
study,! we! observed! a! significant! reduction! in! ubiquitin! conjugation! to! ribosomal!
subunits!at!specific!sites!(RPL9UK21,(RPS27AUK6,(RPS27AUK33,(and(RPS27AU
K48)!in!the!case!of!hyperglycemia/hyperinsulinemia.!On!the!other!hand,!there!was!
a!significant!increase!in!RPS20!ubiquitination!at!the!site!K8!with!high!glucose/high!
insulin!treatment.!These!sites!need!further!investigation!to!unveil!the!impact!of!their!
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different!ubiquitin!conjugation!on!the!protein!synthesis!in!skeletal!muscle!cells!(Fig.!
13QSU).!

Summary(
In!this!project,!we!observed!a!significant!reduction!in!the!total!ubiquitinated!
proteins! in! cases! of! hyperglycemia! and! hyperinsulinemia! in! primary! human!
skeletal!muscle!cells!(Fig!6S10).!Furthermore,!339!ubiquitination!sites!assigned!to!
171! proteins! have! been! identified! in! human! primary! skeletal! muscle! cells! from!
lean,!healthy!subjects.!Among!the!339!sites,!110!sites!were!identified!in!more!than!
half!of!the!samples.!In!addition,!21!sites!among!them!significantly!changed!with!
different!inSvitro!treatments!(including!ACTA1,!ANTXR!1,!CCDC50,!DAG1,!VCP,!
as! well! as! ribosomal! proteins! RPL9,! RPS20,! and! RPS27A).! Because! of! the!
increased! recognition! of! the! importance! of! ubiquitin! proteasomal! pathway! in!
cellular!processes,!our!data!provides!a!list!of!ubiquitination!sites!in!human!skeletal!
muscle!cells!as!a!reference!for!future!research!in!protein!ubiquitination!as!well!as!
diabetes!research.!!
The!future!directions!of!this!study!will!be!validating!these!sites!with!different!
biochemical! approaches,! and! studying! the! most! interesting! sites! showed!
significant! changes! upon! different! treatment! conditions! to! determine! their!
functional!roles!in!insulin!signaling.!To!further!investigate!the!potential!involvement!
of! the! UPS! in! the! development! of! insulin! resistance! in! skeletal! muscle,! future!
efforts!will!be!focused!on!the!effect!of!proteasome!inhibitors!or!Bortezomib!on!the!
reduced!glucose!uptake!in!skeletal!muscle!cells!from!type!2!diabetic!individuals.!
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!
Figure( 1.( PI3kUAktUFOXO( pathway.% The! figure! illustrates! the! role! of! ubiquitinB
dependent!proteasomal!degradation!of!FOXO1!upon!insulin!stimulation![77].!(PKB:!Akt;!
FKHR:!FOXO1)!
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!
!

!
Figure(2.(The(ubiquitinUdependent(proteasomal(degradation(pathway.![78]!
!
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!
!
!

!
Figure(3.((Glucose(Metabolism(during(HyperinsulinemicUEuglycemic(Clamp.(
The! figure! above! shows! the! significant! reduction! in! glucose! uptake! by! skeletal!
muscle! in! diabetics,! while! other! major! glucose! consuming! organs! remain!
unaffected.![79]!!
!
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%
%
%

4!Lean,!healthy!participants,!!
Basal!biopsies!

Participant!Recruitment!
% (e.g.!advertisement,!phone!screening,!
remaindering)!
%
%
%
%
%

Cell!cultures,!2!conditions:!
a. LGNI!
b. HGHI!(Insulin!resistance)!

Primary!Screening!!
(e.g.!OGTT,!Vital!Signs,!Biochemical!
Profile,!BMI,!EKG,!Bioimpedance)!

%

Protein!lysate!
SpikeBin!SILAC!lysate!(1:4!ratio)!
%
Trypsin!inBsolution!digestion!

%
%
%

InB!patient!clinical!testing!
(e.g.!hyperinsulinemicBeuglycemic!
clamps,!muscle!biopsies)!

%

Ubiquitin!remnant!motif!!
(KBɛBGG)!CoBIP!
!

%
%
%
%

!

Comprehensive!analysis!of!plasma!
samples!and!clinical!characteristics!
(e.g.!insulin!sensitivity)!

HPLCBESIBMS/MS!
LTQBOrbitrap!Elite!

%
%
%
%
%

Combination!and!interpretation!of!
clinical!and!proteomics!data!

MaxQuant:!protein!identification!and!
quantification!
DAVID:!pathway!analysis!!

%
Figure(4.(General(flow(chart(of(clinical(and(proteomics(study.(
!
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!
!

Fasting!participant

Setting!up!2!catheters:
1.!Insulin/Glucose!infusion
2.!Plasma!glucose!
measurement

B30!min
First!biopsy

0!min
Starting!Insulin/Glucose!
infusion

+120!min
Last!biopsy

!
Figure(5.(Overview(of(clinical(visit(2(procedures!
!
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!

!
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*
1

0
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!
Figure(6.((Effect(of(HG(on(total(ubiquitination(in(the(basal(condition.(
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(

!

(+)!Insulin!(Total)
Relative%densitometry

2

**
1

0
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!
Figure(7.((Effect(of(HG(on(total(ubiquitination(after(insulin(stimulation(
(
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INS/BAS Total
Relative%densitometry
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!
Figure(8.((Effect(of(insulin(on(total(ubiquitination(level(in(LG(and(HG(
conditions(
(

!

(

!

44!

(A)%
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(B)%

Relative%densitometry

(+)!Insulin!75!KD
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1

0

**
LG%%%%%%%%%%%%%%%%%%%%%%%%%%%%HG
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(C)%

Relative%densitometry

INS/BAS!75KD
2

1

0

LG%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%HG

(
Figure(9.(Ubiquitination(level(at(75(KD:((A,!B)!Effect!of!HG!in!the!basal!and!
insulin!stimulated!conditions.((C)!Effect!of!insulin!in!LG!and!HG!conditions.(
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2

2

0

Relative%densitometry

2

(B)%

N.S.
1

2

(+)!Insulin!50!KD

LG%%%%%%%%%%%%%%%%%%%%%%%%%%HG

!

(+)!Insulin!37!KD

1

0

LG%%%%%%%%%%%%%%%%%%%%%%%%%%HG

!
2

INS/BAS!50!KD

LG%%%%%%%%%%%%%%%%%%%%%%%HG

LG%%%%%%%%%%%%%%%%%%%%%%%%HG

!

1

0

Basal!37!KD

0
LG%%%%%%%%%%%%%%%%%%%HG

*

2

Relative%densitometry

N.S.

1

0

(C)%

Relative%densitometry

1

Relative%densitometry

(A)%

Relative%densitometry

Relative%densitometry

Basal!50!KD

!

INS/BAS!37!KD

1

0

LG%%%%%%%%%%%%%%%%%%%%%%%%HG

!

!

Figure(10.(Ubiquitination(level(at(50(KD(and(37(KD:((A,!B)!Effect!of!HGHI!in!the!
basal!and!insulin!stimulated!conditions.((C)!Effect!of!15Sminute!insulin!treatment!in!
LGNI!and!HGHI!conditions.(
!
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%
%
%
%

339!ubiquitination!sites!identified!via!IP
!
%

%
%
%
%
%

110!out!of!the!339!were!observed!in!more!than!half!of!the!16!
samples!
(e.g.!>!8)(

%
%
%
%

21!sites!have!a!significant!change!in!the!4!sets!of!samples:!
LGNI_BAS,!LGNI_INS,!HGHI_BAS,!HGHI_INS!

%
%
Figure(11.(Detailed(Proteomic(Analysis(workflow(
LGNI_BAS:! low! glucose! no! insulin! and! without! 15! minutes'! insulin! treatment!
before!harvesting!!
LGNI_INS:!low!glucose!no!insulin!and!with!15!minutes'!insulin!treatment!before!
harvesting! HGHI_BAS:! high! glucose! high! insulin! for! 2Sdays! and! without! 15!
minutes'!insulin!treatment!before!harvesting!!
HGHI_INS:! high! glucose! high! insulin! for! 2Sdays! and! with! 15! minutes'! insulin!
treatment!before!harvesting%
!
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protein!degradation

4

mitogenBactivated! protein!kinase!…

4

interleukinB1!receptorBassociated!…

5

p21!protein!(Cdc42/Rac)Bactivated!…

4

glycogen!synthase!kinase!3!beta

5

p21Bactivated!kinase!I

4

NIMA!(never!in!mitosis!gene!a)B…

9

anaphaseBpromoting!complexB…

7
9

Biological%process

regulation!of!protein!ubiquitination
negative!regulation!of!ubiquitinB…

7

positive!regulation!of!ubiquitinB…

9

Ubiquitin!mediated!proteolysis

13

ubiquitinBprotein!ligase!activity

9

proteasomal!ubiquitinBdependent!…

11
12

Ubiquitin!proteasome!pathway
protein!ubiquitination

13
23

ubiquitinBdependent!protein!…
Regulation!of!activated!PAKB2p34!…

6

APC/C:Cdh1Bmediated!degradation!…

7

APCBCdc20!mediated!degradation!…

5

protein!degradation

4

response!to!calcium!ion

5

Cytoskeleton

70
0

5

10
15
(>Log%p>value)

20

25
!

Figure(12.(Significantly(enriched(pathways(identified(in(this(study(revealed(
by(Database(for(Annotation,(Visualization(and(Integrated(Discovery((DAVID)(
(https://david.ncifcrf.gov/).! The! total! number! of! identified! proteins! for! every!
pathway!is!denoted!beside!the!corresponding!bar.!See!(Table!2)!for!more!details.!!
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Figure( 13.( Significantly( changed( ubiquitination( sites( among( the( 4( sets( of(
samples:((
LGNI_BAS:! low! glucose! no! insulin! and! without! 15! minutes'! insulin! treatment!
before!harvesting!!
LGNI_INS:!low!glucose!no!insulin!and!with!15!minutes'!insulin!treatment!before!
harvesting! HGHI_BAS:! high! glucose! high! insulin! for! 2Sdays! and! without! 15!
minutes'!insulin!treatment!before!harvesting!!
HGHI_INS:! high! glucose! high! insulin! for! 2Sdays! and! with! 15! minutes'! insulin!
treatment!before!harvesting%
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Table(1.(Clinical(characteristics(of(participants(in(the(study.(
Results! were! shown! as! mean! ±! SEM.! Normal! values! are! in! Bold( after! BMI,! 2h!
OGTT!glucose,!HBA1c,!and!Fasting!plasma!glucose!values.!!!
!
!

4!participants!in!lean!group!

Gender!(M/F)!

(3/1)!

Age!(years)!

33.75!±!10.45!

2

(
(
(
(
(
(

!

BMI!(kg/m )!

22.25!±!1.09!(<(25)!

2h!OGTT!Glucose!(mg/dl)!

107.78!±!10.03!(<140)!

2h!OGTT!Glucose!(mmol/l)!

5.98!±!0.56!

HBA1c!(%)!

5.4!±!0.14!(<5.7)!

Fasting!plasma!glucose!(mg/dl)!

93.75!±!2.52!(<100)!

Fasting!plasma!glucose!(mmol/l)!

5.21!±!0.14!

MSvalue!(mg/kg/min)!

9.46!±!1.12!

!
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Table.(2.(A(list(of(the(identified(genes(for(the(significantly(enriched(proteins(
by(immunoUprecipitation(in(this(study(assigned(to(their(biological(processes(
according( to( DAVID! (https://david.ncifcrf.gov/):( The! tables! below! show! the!
pathway,!number!of!identified!genes!in!the!pathway,!(Slog!pSvalue),!and!the!gene!
names.!
!

Biological%Process%

Number%of%
Genes%

(>log%p>value)%

Regulation%of%
activated%PAK>2p34%
by%proteasome%
mediated%
degradation%

6!

2.022!

PSMC3,PSMC6,RPS27A,UBA52,UBB,UBC!

Cdc20:Phospho>
APC/C%mediated%
degradation%of%
Cyclin%A%

7!

1.886!

23!

11!

13!

6.698!

PSMC3,PSMC6,RPS27A,UBA52,UBB,UBC,UBE2D1!
RAD23A,RAD23B,SKP1,UBXN1,CUL5,DDB1,ITCH,NED
D4,NEDD8,PSMC3,PSMC6,RPS27A,SQSTM1,UBA52,
UBB,UBC,USP13,USP5,UBE2D1,UBE2D2,UBE2D3,UB
E2NL,VCP!
DDB1,ITCH,LRSAM1,NEDD4,RPS27A,UBA52,UBB,UB
C,UBE2D1,UBE2D2,UBE2D3,UBE2N,VCP!

7!

1.886!

ACTB,ACTG1,CAV1,GSN,NEDD4,TTN,TNNC1!

4!

2.886!

RPS27A,UBA52,UBB,UBC!

6.161!

ITCH,NEDD4,PIP5K1A,PSMC3,PSMC6,UBE2D1,UBE2
D2,UBE2D3,UBE2D4,UBE2N,UBE2NL,UBA1!

11!

5.568!

RAD23A,RAD23B,UBXN1,PSMC3,PSMC6,RPS27A,UB
A52,UBB,UBC,UBE2D1,VCP!

9!

5.050!

BIRC6,ITCH,LRSAM1,NEDD4,UBE2D1,UBE2D2,UBE2D
3,UBE2D4,UBE2N,UBE2NL!

Ubiquitin>
dependent%protein%
catabolic%process%
Protein%
ubiquitination%
Response%to%metal%
ion%
Protein%degradation%
Ubiquitin%
proteasome%
pathway%
Proteasomal%
ubiquitin>
dependent%protein%
catabolic%process%
Ubiquitin>protein%
ligase%activity%
!
!
!

12!

Gene%Names%

!

Biological%Process%
Anaphase>
promoting%complex>
dependent%
proteasomal%
ubiquitin>dependent%
protein%catabolic%
process%
NIMA%(never%in%
mitosis%gene%a)>
related%kinase%2%
p21>activated%kinase%
I%
Glycogen%synthase%
kinase%3%beta%
p21%protein%
(Cdc42/Rac)>
activated%kinase%2%
Interleukin>1%
receptor>associated%
kinase%1%
Mitogen>activated%
protein%kinase%
kinase%kinase%7%
Ubiquitin%mediated%
proteolysis%
Positive%regulation%
of%ubiquitin>protein%
ligase%activity%
Negative%regulation%
of%ubiquitin>protein%
ligase%activity%during%
mitotic%cell%cycle%
Regulation%of%
protein%
ubiquitination%
Cyclin>dependent%
kinase%2%
!
!

!
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Number%of%
Genes%

(>log%p>value)%

7!

3.397!

PSMC3,PSMC6,RPS27A,UBA52,UBB,UBC,UBE2D1!

9!

2.823!

RPS27A,TUBA1A,TUBA4A,TUBB,YWHAG,UBA52,UBB,
UBC,UBE2D1!

4!

3.823!

RPS27A,UBA52,UBB,UBC!

5!

3.508!

SKP1,RPS27A,UBA52,UBB,UBC!

4!

3.292!

RPS27A,UBA52,UBB,UBC!

5!

2.366!

RPS27A,SQSTM1,UBA52,UBB,UBC!

4!

2.013!

13!

3.468!

RPS27A,UBA52,UBB,UBC!
SKP1,BIRC6,CUL5,DDB1,ITCH,NEDD4,UBE2D1,UBE2D
2,UBE2D3,UBE2D4,UBE2N,UBE2NL,UBA1!

9!

5.050!

SKP1,PSMC3,PSMC6,RPS27A,UBA52,UBB,UBC,UBE2D
1,UBE2N!

7!

3.397!

PSMC3,PSMC6,RPS27A,UBA52,UBB,UBC,UBE2D1!

9!

3.920!

SKP1,PSMC3,PSMC6,RPS27A,UBA52,UBB,UBC,UBE2D
1,UBE2N!

6!

1.744!

SKP1,RPS27A,UBA52,UBB,UBC,UBE2D1!

Gene%Names%

!

59!

!
!

Biological%Process%

Number%of%
Genes%

(>log%p>value)%

Gene%Names%

Cytoskeleton%

70!

20.113!

Calcium%ion%binding%
Response%to%calcium%
ion%
Protein%degradation%
APC>Cdc20%mediated%
degradation%of%
Nek2A%

22!

1.537!

ARL2,,ARL8B,JAK1,ACTA1,ACTA2,ACTC1,ACTB,ACTBL2,
ACTG1,ACTG2,ACTN1,ACTN2,ACTN4,ANXA1,CFL1,CFL2
,DES,DYNLRB1,DYNLRB2,DAG1,GSN,HSPB1,TOM1,TUB
A1B,EZR,KRT7,KRT8,LMNA,MSN,MYOM1,MYLPF,MYH
1,MYH13,MYH2,MYH3,MYH4,MYH7,MYH7B,MYH8,M
YL1,MYL12A,MYL12B,MYL4,MYL6,MYL6B,NES,PRPH,P
EA15,PFN1,RDX,TMSB4X,TTN,TRIM54,TRIM55,TPM1,T
PM2,TPM3,TPM4,TNNC1,TNNI1,TUBA1A,TUBA1C,TUB
A3C,TUBA3E,TUBA4A,TUBA8,TUBB,YWHAZ,VIM,VCL!
ATP2B1,S100A11,S100A6,ACTN1,ACTN2,ACTN4,ANXA
1,ANXA2P2,ANXA2,DAG1,GSN,MYLPF,MYL1,MYL12A,
MYL12B,MYL4,MYL6,MYL6B,TTN,TPM4,TNNC1,TTYH3!

5!
4!

2.050!
2.886!

ACTB,ACTG1,CAV1,NEDD4,TTN!
RPS27A,UBA52,UBB,UBC!

5!

2.356!

RPS27A,UBA52,UBB,UBC,UBE2D1!

Cyclin>dependent%
kinase%inhibitor%1A%
(p21,%Cip1)%

5!

1.721!

SKP1,RPS27A,UBA52,UBB,UBC!

Cyclin>dependent%
kinase%inhibitor%1B%
(p27,%Kip1)%

5!

1.721!

SKP1,RPS27A,UBA52,UBB,UBC!

3>phosphoinositide%
dependent%protein%
kinase>1%

4!

1.408!

RPS27A,UBA52,UBB,UBC!

7!

2.036!

PSMC3,PSMC6,RPS27A,UBA52,UBB,UBC,UBE2D1!

APC/C:Cdh1>
mediated%
degradation%of%Skp2%
(
(
!

!

!
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Table(3.(Ubiquitinated(lysine(sites(with(significant(changes(in(the(4(sets(of(
samples;! low! glucose! no! insulin! without! 15! minutes'! insulin! treatment! before!
harvesting!(LGNI_BAS),!low!glucose!no!insulin!with!15!minutes'!insulin!treatment!
before!harvesting!(LGNI_INS),!high!glucose!high!insulin!without!15!minutes'!insulin!
treatment! before! harvesting! (HGHI_BAS),! high! glucose! high! insulin! with! 15!
minutes'!insulin!treatment!before!harvesting!(HGHI_INS)!!!
(

Protein%
ID%
P68133!

ANTXR1!

Q9H6X2B
5!

CCDC50!

Q8IVM0!

DAG1!

Q14118!

EPN1!

Q9Y6I3B3!

ERH!
HIST1H2
B!

G3V279!

ITM2B!

Q9Y287!

MYH3!
(

P11055!

(
(

!

U3KQK0!

193!

1.00!

Position%
GlyGly%(K)%modified%
in%
peptide%sequence%
peptide%
DLTDYLMKILTER!
8!

453!

1.00!

GKLDALWVLLR!

152!

1.00!

AYADSYYYEDGGMKP
R!
14!

794!

0.91!

EpsinB1!
107!
Enhancer!of!
rudimentary!
homolog! 12!

1.00!

LTLEDQATFIKK!
ENMYAVQTLKDFQY
VDR!

10!

3!

B0.178!

1.00!

SHTILLVQPTKRPEGR! 11!

3!

B0.280!

Histone!H2B! 121!
Integral!
membrane!
protein!2B! 13!

1.00!

AVTKYTSSK!

4!

2!

0.154!

1.00!

VTFNSALAQKEAK!
TKCEESQAELEASLKE
SR!

10!

2!

0.318!

15!

3!

B0.266!

Protein%
names%
Actin!
Anthrax!
toxin!
receptor!1!
CoiledBcoil!
domainB
containing!
protein!50!
Dystroglyca
n!

MyosinB3!

1473!

1.00!

Charge%

Localization%
probability%

Gene%
names%
ACTA1!

Positions%
Within%
Proteins%

(

2!

Mass%
error%
[ppm]%
0.122!

3!

B1.401!

3!

B0.115!

12!

3!

0.122!

2!

!
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(

Protein%
names%
MyosinB3!
MyosinB3!
MyosinB3!
60S!
ribosoma
l! protein!
L9!
RPS20! E5RIP1! 40S!
ribosoma
l! protein!
S20!
RPS27A! P62979! Ubiquitin
B40S!
ribosoma
l! protein!
S27a!
RPS27A! P62979! Ubiquitin
B40S!
ribosoma
l! protein!
S27a!
RPS27A! P62979! Ubiquitin
B40S!
ribosoma
l! protein!
S27a!
SPG20! Q8N0X7! Spartin!
(
(
(
(

!

Protein%
ID%
P11055!
P11055!
P11055!
E7ESE0!

1484!
1807!
1920!
21!

1.00!
0.99!
1.00!
1.00!

8!

1.00! DTGKTPVEPEVAIHR!

4!

3!

B0.426!

6!

1.00! MQIFVKTLTGK!

6!

2!

B0.141!

33!

1.00! IQDKEGIPPDQQR!

4!

3!

B0.544!

48!

1.00! LIFAGKQLEDGRTLSDY
NIQK!

6!

3!

B
0.0925!

362!

1.00! TRPSSDQLKEASGTDVK! 9!

3!

B0.468!

GlyGly%(K)%modified%
peptide%sequence%
SLSTELFKLK!
LDEAEQLALKGGK!
ADIAESQVNKLR!
TILSNQTVDIPENVDITL
KGR!

Charge%

Localization%
probability%

Gene%
names%
MYH3!
MYH3!
MYH3!
RPL9!

Positions%
Within%
Proteins%

(

Position%
in%
peptide%
8!
10!
10!
19!

3!
2!
3!
3!

Mass%
error%
[ppm]%
B0.871!
B0.070!
B0.387!
B0.109!

!
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(

Localization%
probability%

440!

1.00!

P55072!

Transitional! 668!
endoplasmic!
reticulum!
ATPase!

1.00!

SPVAKDVDLEFLAK!

5!

3!

0.737!

P09493!

Tropomyosi 37!
n! alphaB1!
chain!

1.00!

SKQLEDELVSLQK!

2!

3!

0.181!

Gene%
names%
TUBA!

Protein%
Protein%
ID%
names%
F5H5D3! Tubulin!
alpha!

VCP!

TPM1!

(
(
(
(
(
(
(
(
(
(
!

!

GlyGly%(K)%modified%
peptide%sequence%
VGINYQPPTVVPGGDL
AKVQR!

Charge%

Positions%
Within%
Proteins%

(

Position%
in%
peptide%
18!
3!

Mass%
error%
[ppm]%
B0.343!

!
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ABSTRACT(
PROTEIN(UBIQUITINATION(IN(PRIMARY(HUMAN(SKELETAL(MUSCLE(
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!
(

Ubiquitin!proteasome!system!is!a!relatively!newly!discovered!pathway!for!

protein! degradation.! Many! studies! have! successfully! pointed! out! the! critical!
functions!that!UPS!plays!in!regulating!many!physiological!processes.!On!the!other!
hand,!recent!studies!suggested!that!abnormal!UPS!activities!might!be!involved!in!
the!pathophysiology!of!several!disorders!including!type!2!diabetes.!However,!the!
specific! changes! in! UPS! during! the! development! of! insulin! resistance! and!
consequently!T2D!are!still!unclear.!!
!

UPS!is!composed!of!two!major!steps,!a!reversible!ubiquitin!conjugation!to!

the! targeted! substrate! followed! by! proteasomal! degradation! of! the! ubiquitinated!
proteins.!In!this!study,!we!examined!the!changes!in!the!total!ubiquitination!as!well!
as! the! siteSspecific! ubiquitin! conjugation! under! hyperinsulinemicShyperglycemic!
conditions!in!primary!skeletal!muscle!cells!derived!from!lean,!healthy!people.!We!

!

!

observed!a!significant!decrease!in!the!total!ubiquitination!in!case!of!glucotoxicity,!
which!is!a!simulation!for!insulin!resistance!in!cell!culture.!In!addition,!we!identified!
21! ubiquitination! sites! that! showed! significant! changes! upon! treatment! with!
different! glucose! and! insulin! concentrations.! This! study! provides! a! list! of!
ubiquitination!as!a!reference!for!future!research!in!ubiquitination!and!diabetes!in!
human!skeletal!muscle!cell.
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